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Abstract
Objectives: Esophageal complication is common in patients with systemic sclerosis (SSc). The 
relationship between gastroesophageal reflux (GER) symptoms and dysmotility was examined in 
endoscopically confirmed patients with suspected of having reflux esophagitis.
Methods: A total of 32 patients with limited and diffuse type SSc (lSSc, dSSc) were examined 
based on a structured questionnaire score (QS) of GER symptoms, retention fraction of 
esophageal scintigraphy at 90 seconds (R90) and gastric emptying time.
Results: The QS was significantly higher in the reflux esophagitis group than in the non-
esophagitis group (5.4 ± 3.5, 1.4 ± 2.9, p=0.003). When the non-esophagitis group was further 
divided into lSSc and dSSc groups, R90 was higher in the reflux esophagitis group (31% ± 18%) 
and the non-esophagitis group with dSSc (34% ± 32%) than in the non-esophagitis group with 
lSSc (8% ± 3%, p=0.02). Both high R90≥15% and QS≥4 indicated reflux esophagitis. Conversely 
both normal R90 and QS indicated no reflux esophagitis. 
Conclusion: A combination of esophageal scintigraphy and structured questionnaire demonstrated 
different aspects of esophageal dysfunction, namely dysmotility and GER. Patients with high QS 
and dysmotility may be indicated for further evaluation including endoscopic examination and 
medical treatment.
Key words: systemic sclerosis, esophageal transit scintigraphy, esophageal dysmotility, 
gastroesophageal reflux, structured questionnaire
Introduction
Systemic sclerosis (SSc) is a generalized disorder 
involving multiple organs and tissues of heart, lung, 
kidney and gastrointestinal tracts. [1] Of these 
generalized involvements, typical esophageal 
complications include dysphagia and esophageal 
reflux. Major esophageal and gastric complications 
seem to be related to neuropathy of the 
gastrointestinal nervous system and collagen 
deposition or fibrosis in the smooth muscle layer. 
 Since the 1980's, nuclear studies have 
shown the usefulness of esophageal transit 
scintigraphy to identify transit disorders, and high 
prevalence of transit delay or retention has been 
demonstrated in patients with SSc. [2-9] As an 
indicator of dysmotility in both early and advanced 
disease, a study has demonstrated that esophageal 
scintigraphy has a higher sensitivity than that of 
manometry and barium swallows [3], although new 
manometric techniques have been developed 
currently. However, the relationship between 
nuclear esophageal transit studies and reflux 
esophagitis has not been defined yet. When 
symptoms are typical for gastroesophageal reflux 
(GER), effective response to medication such as 
proton-pump inhibitors may further support the 
diagnosis of GER. Considering the high morbidity 
of GER, careful examination is required in patients 
with gastrointestinal abnormalities even for those 
patients without symptoms. [10] A nuclear 
esophageal transit study might reflect motility after 
ingestion and thus might not directly detect 
esophagitis.
 Thus, we hypothesized that combined use 
of structured GER symptom scoring and an 
esophageal transit study can differentiate the nature 
of esophageal complications. The aims of this study 
were to evaluate the incidence of esophageal transit  
and gastric emptying abnormalities in comparison 
with GER symptoms in patients with 
endoscopically confirmed reflux esophagitis.
Methods
Patients 
A total of 32 patients (24 females and 8 males, 
average age 58 ±12 (SD) years) were examined 
based on esophageal transit and gastric emptying 
studies. The patients were diagnosed with systemic 
sclerosis (SSc) in the Department of Dermatology 
at Kanazawa University based on American 
Rheumatism Association diagnostic criteria. The 
final diagnosis of SSc was made based on skin 
lesions, serological examinations and multiple 
organ surveys. The classification into diffuse and 
limited cutaneous SSc types (dSSc, lSSc) was 
based on skin lesions, other clinical findings and 
laboratory data according to LeRoy et al. [11, 12] 
All the patients underwent esophageal and gastric 
endoscopy for the diagnosis of reflux esophagitis 
and were classified by the standard Los Angeles 
classification system. [13] Chest X-ray and 
respiratory function were evaluated for the 
diagnosis of interstitial lung disease.
 The study protocol was approved by 
Institutional Review Board of Kanazawa 
University. Written informed consent was obtained 
from all patients.
Esophageal transit study
 Technetium-99m (99mTc) 
diethylenetriaminepentaacetic acid (DTPA) was 
mixed in a semi-liquid enteral feeding formula 
(Racol(R), Otsuka Pharmaceutical Company Ltd, 
Japan), which included 200kcal with 8.76 g of 
protein, 4.46 g of lipids, and 31.24 g of 
carbohydrates in addition to vitamins and minerals 
per 200 mL. Patients were instructed to retain 7-10 
mL of the liquid, in which ~10 MBq of Tc-99m was 
mixed, and to swallow one gulp. After 30 seconds, 
the patients repeated dry swallows during each 15-
second interval. After practice attempts of several 
swallows, the studies were repeated twice in the 
sitting and supine positions, but only the results 
from the supine position were analyzed in this 
study. [9] The fragmentation of the bolus in the 
swallow could be avoided by the practice of using 
unlabeled liquid. Serial anterior images were 
acquired in 64 x 64 matrices for 96 seconds at 0.5 
seconds per frame. A large rectangular field of view 
camera (53 x 39 cm) equipped with a low-energy 
high-resolution collimator (ecam, Toshiba/Siemens, 
Tokyo, Japan) was used. After the esophageal 
transit study, the remaining semi-liquid meal (~180 
mL) was ingested in one minute, resulting in 200 
mL in the stomach. The images of the stomach 
were obtained in the left anterior oblique projection 
at 3, 10, 20, 30, 45, 60 and 90 minutes after 
ingestion. 
Structured questionnaire
To evaluate the GER symptom, a structured 
questionnaire was used. [14, 15] The questionnaire 
was comprised of scoring of (1) the nature of main 
discomfort, (2) the timing of the symptoms, (3) 
relation to the food type, (4) effects of ingestion 
medicine, (5) effects of bending or stooping, (6) 
effects of straining and lifting and (7) changes of 
symptoms after return of food or acid (Table 1). 
The threshold score of 4 or more was used for 
suggesting reflux esophagitis. [16] The summed 
score ranged from -7 to 18 points, in which the 
higher points indicated severer reflux symptoms.
Data analysis
After observing tracer transit on a cinematic 
display, esophageal transit was analyzed by time-
activity curves as previously described. [9] A 
region of interest (ROI) was drawn over the whole 
esophagus ranging from the upper esophagus to the 
gastroesophageal junction. The retention fraction at 
90 seconds (R90) was defined as the retained 
activity at 90 seconds divided by the maximum 
activity of the time-activity curve. To calculate 
gastric emptying time, manual ROIs were set on 
the stomach and the time-activity curve was 
plotted. The retention fraction at 60 minutes (%) 
and half emptying time (min) were calculated by 
exponential fitting.
Statistics
Values were expressed as a mean ± standard 
deviation (SD).  The differences of the variance and 
mean values were examined by a multiple-
comparison test following a significant finding in 
the one-way analysis of variance (ANOVA).  The 
difference of the contingency table was examined 
by chi-square and likelihood ratio and Pearson p-
values. A p value < 5% was considered significant.
Results
  
The questionnaire score (QS) and esophageal R90 
in SSc types are summarized in Table 2. Both high 
and low QS were observed in the dSSc and lSSc 
groups (p=n. s.), while high R90 >15% was 
observed in 12 of 18 (67%) patients in the dSSc 
type and 3 of 14 (21%) in the lSSc type. The 
frequency of reflux esophagitis did not differ 
significantly between dSSc and lSSc groups
 When QS and R90 were compared with 
esophageal hernia (n=3) excluded, the numbers of 
patients in groups with high QS≥4 and high 
R90≥15%, high QS≥4 and low R90<15%, low 
QS<15% and high R90≥15% and low QS and low 
R90<15% were 5, 4, 9 and 11 (p=n. s. by χ2 
analysis). Distribution of R90 and QS with regard 
to reflux esophagitis is shown in Figure 1. When 
both QS and R90 were high, all patients had reflux 
esophagitis except for a case with esophageal 
hernia. When both QS and R90 were low, no 
patient with reflux esophagitis was included. 
However, retention-dominant (high R90) and 
symptom-dominant (high QS) patients were also 
noted. Reflux esophagitis was observed in 70% 
(3/10) of the dysmotility-dominant group and in 
50% (2/4) in the reflux symptom-dominant group.
 Esophageal and gastric transit studies are 
summarized in patients with endoscopically 
confirmed reflux esophagitis (Table 3).  The QS 
was significantly higher in patients with reflux 
esophagitis (5.4±3.5) than those without (1.4±2.9) 
(p=0.003), while R90 did not reach statistical 
significance. Gastric retention at 60 minutes and 
half-emptying time did not differ between both 
groups.   
 Patients without reflux esophagitis were 
divided into lSSc (n=10) and dSSc (n=10) 
subgroups and compared with esophageal reflux 
groups (n=9) (Table 4). Both R90 and QS differed 
significantly among the three groups. The R90 was 
higher in dSSc without esophagitis and reflux 
esophagitis, and the QS was higher in patients with 
reflux esophagitis. Gastric retention did not differ 
significantly among three groups. Total skin 
thickness score was slightly higher in the reflux 
esophagitis group and the non-esophagitis group 
with dSSc compared with the non-esophagitis 
group with lSSc (p=0.05).
 Interstitial lung disease was observed in 13 
of 18 (72%) with dSSc and 3 of 14 (21%) lSSc 
types (p=0.004 by Pearson statistics). When 
patients without esophagitis were similarly divided 
into lSSc and dSSc groups, interstitial lung disease 
was observed in 2 (20%) with lSSc and in 7 (70%) 
with dSSc in comparison with 5 (56%) with reflux 
esophagitis (n. s., p=0.07 by Pearson statistics).
Discussion
An esophageal transit study combined with a 
structured questionnaire for GER could 
characterize the esophageal complication in SSc. 
Patients with both positive QS and dysmotility 
highly indicated reflux esophagitis. Conversely, 
patients with good motility and normal QS 
indicated no reflux esophagitis. Two aspects of 
dysfunction in SSc, namely, dysmotility-dominant 
and GER symptom-dominant groups, were 
separately evaluated in this study.
 In multiple organ involvements associated 
with SSc, digestive systems were most frequently 
involved including esophagus, duodenum and small 
and large intestines.[1] The common underlying 
pathology was atrophy of smooth muscles and 
fibrous changes, which resulted in peristaltic 
disturbances. The incidence of complication in the 
digestive system was approximately 50 to 80%, and 
the abnormal esophageal scintigraphic findings 
were found in 70-90% of patients. [2-5, 8] This 
study showed abnormal esophageal retention in 
~70% of dSSc type and ~20% of lSSc type, 
demonstrating a difference in SSc types. However, 
all patients with esophageal scintigraphic 
abnormality did not necessarily have subjective 
symptoms. In general, the most frequent site of 
involvement was in the esophagus, followed by 
small and large intestines, and the site of the 
stomach was less frequent. [7, 17, 18]
 Common esophageal manifestations in SSc 
include motility abnormalities, GER, Barrett's 
esophagus, adenocarcinoma, infectious esophagitis, 
and drug-induced esophagitis.[10] The GER 
symptom which was not associated with 
pathologically-confirmed reflux esophagitis might 
be actually more common. The symptom of 
heartburn was aggravated by bending forward, 
straining, or lying recumbent. In this study, the 
diagnosis of reflux esophagitis was endoscopically 
made based on visible pathological changes. 
Although scintigraphic abnormality with GER 
symptoms was considered false positive if the 
pathological change was not evident by endoscopic 
study, actual functional abnormality could not be 
denied. However, since esophagitis was determined 
by strict definition using an endoscope, this study 
may be used to find the appropriate candidates for 
further endoscopic examinations.
 The usefulness of the structured 
questionnaire was examined, since the symptoms 
were somewhat vague based on the complaints of 
the patients. A study showed that the questionnaire 
had a sensitivity of 92% but a low specificity of 
19%. [15] The diagnostic test characteristics of the 
questionnaire were comparable with those of the 
physician's provisional classification. [14] 
However, the questionnaire score was successfully 
used to evaluate treatment of GER with proton-
pump inhibitors. [19] A Japanese study using this 
questionnaire (Osaka GERD study) showed that 
diagnostic performance of the score using a 
threshold of ≥4 showed sensitivity of 72%, 
specificity of 54% and accuracy of 56% to predict 
reflux esophagitis in 675 patients (347 males and 
328 females) who underwent endoscopic 
examination. [16] Thus, the diagnostic ability of 
this symptomatic questionnaire alone was still 
limited, but the scoring system could be used to 
semi-quantify subjective GER symptoms as an 
adjunct to a non-invasive nuclear esophageal transit  
study. 
 Esophageal retention after repeated 
swallowing was higher in dSSc patients than in 
lSSc patients, which was comparable with findings 
of precedent studies, although lSSc patients may 
have had reflux esophagitis. [9, 20] In patients with 
endoscopic evidence of esophagitis, the QS was 
significantly high and was considered to 
correspond to patient GER symptoms. On the other 
hand, R90 was relatively high in patients with 
endoscopically confirmed esophagitis, but it was 
not significant. Therefore, esophageal reflux and 
peristaltic abnormality seemed to show different 
aspects of the esophageal complications in patients 
with SSc. In addition, gastric emptying time did not  
correlate with reflux esophagitis. A study using 
solid meal revealed 57% abnormality in gastric 
emptying, while delayed esophageal transit was 
abnormal in 73%. [18] The study also found weak 
correlation between esophageal transit time and 
gastric emptying time using a solid meal. The lower 
frequency of gastric abnormality in our study may 
be related to the food type as we used semi-liquid 
meal, and it may also have been related to the 
characteristics of the patient population.
 Patients who underwent endoscopy were 
examined, but control patients were not included. 
The lSSc patients who had no evidence of 
esophagitis were the least severe groups, and 
parameters of esophageal transit and gastric 
emptying were comparable with those of the 
control patients in our preceding study. [9, 21] The 
mean QS was also within normal range in this lSSc 
group. 
 Higher prevalence of interstitial lung 
disease in patients with severe esophageal motor 
impairment was demonstrated, and it suggested that 
GER might be one of the contributing factors of 
interstitial lung disease. [20, 22, 23] 
Comprehensive follow-up will be required since 
SSc involves multiple organs, particularly in 
digestive systems, lung, heart and kidney in 
addition to scleroderma changes. Appropriate non-
invasive evaluations for complications would lead 
to early diagnosis and management of the SSc 
patients.
 The number of patients was limited, 
because all non-symptomatic patients with SSc 
could not be diagnosed by endoscopic 
examinations. The relationship between the 
severity by Los Angeles classification and QS or 
R90 could not be analyzed because of the limited 
number in each subgroup. Esophageal sliding and/
or hiatus herniation showed abnormal transit 
patterns, but this could not be differentiated by 
scintigraphy and a questionnaire. However, typical 
herniation may be diagnosed by an X-ray 
esophageal barium study or X-ray CT. 
 In conclusion, patients with high R90 
(dysmotility) and high QS (reflux symptom) 
strongly suggested reflux esophagitis, and further 
endoscopic examination or treatment strategy 
would be required. In contrast, patients with both 
normal R90 and QS may not be indicated for 
endoscopic examination. The GER-dominant group 
and dysmotility-dominant group suggested 
different aspects of esophageal dysfunction.
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Figure 1
Esophageal retention fraction at 90 seconds (R90) and questionnaire score for GER symptoms (QS). 
Endoscopic findings were classified into 4 groups using threshold values of R90=15% and QS=4 points.
Table 1. Questionnaire for scoring gastroesophageal reflux symptoms
Please answer the following questions by ticking one box only, except for Q3, where you must tick one box 
for each statement. 
________________________________________________________________________________
Q1. Which one of following statements best describes the main discomfort in your stomach or chest? 
(5) □ A burning feeling rising from your stomach or lower chest up to your neck 
(0) □ Feelings of sickness or nausea 
(2) □ Pain in the middle of your chest when you swallow 
(0) □ None of the above, please describe below: 
Q2. Please choose which one of the next statements best describes the timing of your main discomfort? 
(-2) □ Any time, not made better or worse by taking food 
(3) □ Most often within 2 hours of taking food 
(0) □ Always at a particular time of day or night without any relationship to food 
Q3. How do the following affect your main discomfort? 
Worsens  Improves  No effect/Unsure 
○ Larger than usual meals  (1) □ (-1) □ (0) □
○ Food rich in fat   (1) □ (-1) □  (0) □ 
○ Strongly flavored or spicy food (1) □ (-1) □ (0) □
Q4. Which one of the following best describes the effect of indigestion medicines on your main discomfort? 
(0) □ No benefit  (3) □ Relief within 15 minutes  (0) □ Relief after 15 minutes 
(0) □ Not applicable (I don’t take indigestion medicines) 
Q5. Which of the following best describes the effect of lying flat, stooping, or bending on your main 
discomfort? 
(0) □ No effect  (1) □ Makes it worse  (-1) □ Gives relief 
(0) □ Don’t know 
Q6. Which of the following best describes the effect of lifting, straining or any other activity that makes you 
breath heavily on your main discomfort? 
(0) □ No effect  (1) □ Makes it worse  (-1) □ Gives relief 
(0) □ Don’t know or this does not apply to me 
Q7. If food or acid-tasting liquid returns to your throat or mouth what effect does it have on your main 
discomfort? 
(0) □ No effect  (2) □ Makes it worse  (0) □ Gives relief 
(0) □ Don’t know or this does not apply to me 
________________________________________________________________________________
The weighted scores within parentheses were added to obtain the diagnostic score. These scores were not 
disclosed on the questionnaire form. 
Table 2
Diffuse versus limited cutaneous types of systemic sclerosis
? Diffuse Limited p values
Number 18 14
Age 56 ± 14 61 ± 10 n. s.
Esophageal R90 (%) 31 ± 27 16 ± 14 n. s. (0.06)
High R90≥15% 12 (67%) 3 (21%) 0.009*, 0.02**
QS (points) 2.5 ± 3.9 2.7 ± 3.1 n. s.
High QS≥4 5 (28%) 5 (36%) n. s.
Gastric retention at 60 min (%) 34 ± 13 41 ± 13 n. s. 
Gastric half-emptying time (min) 41 ± 16 49 ± 20 n. s. 
Reflux esophagitis 6 (33%) 3 (21%) n. s.
QS, Questionnaire score; R90, retention (%) at 90 seconds
P values of likelihood ratio* and Peason statistics**
Table 3








   R90 (%) 21 ± 26 31 ± 18 n. s.
Questionnaire
   QS (points) 1.4 ± 2.9 5.4 ± 3.5 0.003
Gastric emptying study
   Retention at 60 min (%) 39 ± 13 31 ± 8 n. s.
   Half-emptying time (min) 47 ± 16 35 ± 8 n. s.
Table 4




? Limited SSc Diffuse SSc ? ?
Number 10 10 9
Esophageal transit study
   R90 (%) 8 ± 3 34 ± 32 31 ± 18 0.02
Questionnaire
   QS (points) 1.6 ± 2.8 1.2 ± 3.2 5.4 ± 3.5 0.01
Gastric emptying study
   Retention at 60 min (%) 41 ± 10 37 ± 16 31 ± 8 n. s.
   Half-emptying time (min) 47 ±15 46 ± 18 35 ± 8 n. s.
Scleroderma
  Total skin thickness score 5 ± 2 22 ± 13 29 ± 12 0.05
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